Bemarituzumab in patients with FGFR2b-selected gastric or gastro-oesophageal junction adenocarcinoma (FIGHT): a randomised, double-blind, placebo-controlled, phase 2 study

Palermo TM, Li R, Zhou C, Aalfs H, Cress G, Lowe M, Abu-El-Haija M, Chugh A, Downs EM, Fishman DS, Freeman AJ, Giefer MJ, Gonska[...]

Feng J, Chen S, Li Q, Long Y, Ma Y, Zhang L, Zeng R, Luo D, Meng M, Yu S, Chen C, Wu Y, Huang[...]

Yang HJ, Corson M, Aja E, Spartz E, Limketkai BN, Jacobs JP. Protein-Calorie Malnutrition Is Associated with Altered Colonic Mucosal Microbiota in Inflammatory Bowel Disease.[...]